Richard Brady, Ph.D.

Richard Brady, Ph.D., is a Managing Director at Intensity with expertise in microeconomics and financial analysis. Dr. Brady’s experience includes high-stakes litigation matters involving the life sciences, biotechnology, consumer technology, pharmaceuticals, telecommunications, semiconductor, software-as-a-service (SaaS), music, tobacco, and tech industries.

Dr. Brady has taken the lead on several of Intensity’s matters at the International Trade Commission and in several high-profile cases in U.S. District Courts. Notably, he managed Intensity’s work on the Juno Therapeutics v. Kite Pharma matter from the pre-litigation phase through trial completion and was instrumental in helping secure a full damages award for Intensity’s client, Juno Therapeutics. Outside the context of litigation, Dr. Brady has provided strategic licensing guidance to companies with foundational patent portfolios.

Known for his responsiveness to client requests, Dr. Brady is sought for his ability to deliver thorough and detailed analyses under a tight deadline, even delivering substantive work product within 24 hours when needed. According to Intellectual Asset Management (IAM), Dr. Brady “has a remarkable ability to digest and synthesize complicated records” and “is a driving force in developing damages theories [and] in preparing the lengthy and detailed expert reports necessary for complex cases.” IAM also added that Dr. Brady’s “skill, intelligence, work ethic and tenacity make him indispensable.”

Dr. Brady has applied his expertise on economic issues pertaining to intellectual property disputes, financial matters, contract and commercial disputes, licensing issues, and antitrust & competition. His experience includes:

• Lost profits
• Reasonable royalties
• Economic domestic industry
• Unjust enrichment
• Competition
• Music copyright and trademark valuation
• Public interest analysis
• Commercial success
• Prejudgment interest
• Injunctive relief
• Bond analysis
• Market definition
• Irreparable harm
• Breach of contract
• Loss in company value

Dr. Brady was recognized as a top U.S. economic expert and rising star by IAM in 2020, 2021, 2022, and 2023. He earned his Ph.D. in Economics from the University of California, San Diego, his M.A. in Economics from Duke University, his M.S. in Finance from the University of Memphis, and his B.S. in Finance and Management from Christian Brothers University.

Dr. Brady has published economic research in several peer-reviewed academic journals – including Econometrica, Social Choice and Welfare, Games and Economic Behavior, and Judgement and DecisionMaking.